News Releases

Select year
Categories

Myriad Genetics and Personalis Partner to Market Solutions to Pharma Customers

Nov 16, 2023 | Corporate | Products

Read more

Myriad Genetics to Participate in Stephens Annual Investment Conference

Nov 09, 2023 | Corporate

Read more

Myriad Genetics Announces Pricing of Upsized Offering of Common Stock

Nov 08, 2023 | Financial | Corporate

Read more

Myriad Genetics Announces Proposed Offering of $100 Million of Shares of Common Stock

Nov 08, 2023 | Corporate | Financial

Read more

Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth; Raises 2023 Revenue Guidance and Introduces 2024 Revenue Guidance

Nov 06, 2023 | Financial | Corporate

Read more

Myriad Genetics Appoints Sam Raha as Chief Operating Officer

Nov 01, 2023 | Corporate

Read more

Myriad Genetics to Release Third Quarter Financial Results on November 6, 2023

Oct 31, 2023 | Corporate | Financial

Read more

QIAGEN and Myriad Genetics partner to advance companion diagnostics development for cancer

Oct 26, 2023 | Products | Corporate

Read more

Myriad Genetics Issues 2022 Environmental, Social and Governance Report

Sep 19, 2023 | Corporate

Read more

Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work

Sep 06, 2023 | Corporate

Read more

Myriad Genetics to Participate in Morgan Stanley Global Healthcare Conference

Sep 05, 2023 | Corporate | Financial

Read more

Myriad Genetics to Host Investor Day on September 19, 2023

Aug 17, 2023 | Corporate

Read more

Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth

Aug 03, 2023 | Financial | Corporate

Read more

Myriad Genetics to Participate in Goldman Sachs Healthcare Conference

Jun 07, 2023 | Corporate | Financial

Read more

Myriad Genetics Highlights Latest Oncology Portfolio Advancements and New Data at ASCO 2023

Jun 01, 2023 | Products | Corporate

Read more

Adam Brufsky, MD, PhD, FACP Named Oncology Scientific Advisor to Myriad Genetics

May 31, 2023 | Corporate

Read more

Myriad Genetics Earns 2023 Great Place to Work Certification™

May 08, 2023 | Corporate

Read more

Myriad Genetics Reports First Quarter 2023 Financial Results; Achieves 10% Revenue Growth Year-Over-Year, the Second Consecutive Quarter of Double-Digit Year-Over-Year Revenue Growth; Raises Mid-Point of 2023 Revenue Guidance Range

May 03, 2023 | Corporate | Financial

Read more

Myriad Genetics to Participate in BofA Securities Healthcare Conference

May 02, 2023 | Corporate

Read more

Myriad Genetics to Release First Quarter Financial Results on May 3, 2023

Apr 26, 2023 | Financial | Corporate

Read more

Myriad Genetics and SimonMed® Imaging Collaborate to Advance Precision Medicine with New Genetic Risk Assessment Program

Apr 12, 2023 | Products | Corporate

Read more

Illumina and Myriad Genetics expand partnership to broaden access to HRD testing in the United States

Mar 02, 2023 | Products | Corporate

Read more

Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight® Volumes

Feb 28, 2023 | Financial | Corporate

Read more

Myriad Genetics to Release Fourth-Quarter Financial Results on Feb. 28, 2023

Feb 22, 2023 | Financial | Corporate

Read more

Myriad Genetics to Participate in Upcoming Healthcare Conferences

Feb 09, 2023 | Financial | Corporate

Read more

Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference

Jan 04, 2023 | Corporate | Financial

Read more